Looking to discuss the latest developments in competition law in the pharma sector? Here’s an event for you
 |
| Hotel The Hotel in Brussels |
Competition
law has a de facto capital in Europe, and that place is Brussels. Our friends
at KNect365 wish to let IPKat readers know that they are organizing a conference in this city to discuss the latest development in this area of the law
as applied to the pharmaceutical sector.
The
conference, which will be held on 4 December 2018, will feature speakers from
the European Commission and national regulators, as well as in-house counsel
and eminent lawyers from across the industry.
The other
good news is that readers of this blog are entitled to a 15% discount: just
click here and use the VIP code FKW82867IPKE to register.
Do you want to reuse the IPKat content? Please refer to our
Policies section.
If you have any queries or requests for permission, please get in touch with the IPKat team.
Comments
Post a Comment
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html